Peptide-based development of PKA activators

Shirin Kahremany, Michael Zhenin, Yulia Shenberger, David Maimoun, Gianni Colotti, Michael Arad, Asher Shainberg, Hanoch Senderowitz, Sharon Ruthstein*, Arie Gruzman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Protein kinases are among the most important regulators of cellular homeostasis, regulating many aspects of the cell life cycle through phosphorylation. The threonine/serine kinase cAMP-dependent protein kinase (PKA) is a major intracellular effector for a variety of bioactive molecules and hormones that work via a cAMP signaling pathway. In this work we report the discovery of a peptide and its simple peptidomimetic derivatives, which can activate the PKA catalytic unit. The direct binding of these new compounds to PKA and their resulting and activation mode were demonstrated by cellular (cardiomyocytes) and in vitro methods. Activation of PKA in cardiomyocytes after myocardial infarction might be a promising therapeutic strategy to protect the heart from ischemia and reperfusion. In addition, small-molecule PKA activators may prove useful as pharmacological tools for studying transduction mechanisms related to PKA. Several small molecules, which can activate a regulatory PKA unit, were developed. However, no small molecules that can activate a PKA catalytic unit were described in the scientific literature.

Original languageEnglish
Pages (from-to)18585-18597
Number of pages13
JournalNew Journal of Chemistry
Issue number23
StatePublished - 2018


FundersFunder number
Israeli Science Foundation763/10
Wolf Foundation
Bar-Ilan University


    Dive into the research topics of 'Peptide-based development of PKA activators'. Together they form a unique fingerprint.

    Cite this